Anaplastic lymphoma kinase (ALK) is an RTK and an oncogenic driver in non–small-cell lung cancer (NSCLC), anaplastic large-cell lymphoma, and IMT, among other tumors. The gene discussed is ALK; the disease is inflammatory myofibroblastic tumor.